High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma.
Lei LiYong-Dong LiuYu-Ting ZhanYing-Hui ZhuYan LiDan XieXin-Yuan GuanPublished in: Thoracic cancer (2018)
Our study revealed that CCL2 and CCL4 expression levels could serve as potential prognostic biomarkers and therapeutic targets for NSCLC patients.